Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes clinical trials
1 of 1 indexed Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes trials are currently recruiting.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes: 1 US clinical trial tracked, 1 recruiting.
Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is UNC Lineberger Comprehensive Cancer Center, running 1 of these trials.
Enrollment posture brief
Registry condition polyneuropathy-organomegaly-endocrinopathy-monoclonal-gammopathy-and-skin-change
OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
Phase data not available
Top Sponsors
US sites by state
Facility locations filed on Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- UNC Lineberger Comprehensive Cancer Center sponsors the most Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes trials on record, review their full trial history before evaluating a specific study. See UNC Lineberger Comprehensive Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes condition card totals 1 registered trials; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.